Home › Funds › KINGDON CAPITAL MANAGEMENT, L.L.C. › ZVRA
KINGDON CAPITAL MANAGEMENT, L.L.C. position in ZVRA
ZEVRA THERAPEUTICS INC · Health Care
KINGDON CAPITAL MANAGEMENT, L.L.C. reported holding 775,000 shares of ZVRA (ZEVRA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$11.1M, representing 1.22% of its reported portfolio and ranking #29 among its reported holdings. KINGDON CAPITAL MANAGEMENT, L.L.C. has disclosed ZVRA holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How KINGDON CAPITAL MANAGEMENT, L.L.C.'s ZVRA position evolved
KINGDON CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in ZVRA in Q2 2025 at 450,000 shares (US$4.0M). The position peaked in Q2 2026 at 775,000 shares, worth US$11.1M. Across 5 filings, KINGDON CAPITAL MANAGEMENT, L.L.C. increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 775,000 shares valued at US$11.1M. Notable position changes include a 44% increase in Q3 2025 (shares fell 6% over the following quarter), a 32% increase in Q1 2026 (shares rose 54% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 450.00K | $3.96M | New |
| Q3 2025 | 650.00K | $6.18M | Add |
| Q4 2025 | 585.07K | $5.24M | Reduce |
| Q1 2026 | 775.00K | $7.22M | Add |
| Q2 2026 | 775.00K | $11.11M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZVRA and 13F data
ZVRA (ZEVRA THERAPEUTICS INC) is a Health Care company. 56 other funds we track also report a position in ZVRA — the largest reported positions include Nantahala Capital Management, LLC (US$25.8M), 683 Capital Management, LLC (US$12.3M), Retirement Planning Co of New England, Inc. (US$6.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZVRA
- Nantahala Capital Management, LLC 1.80M sh · $25.78M · Q2 2026
- 683 Capital Management, LLC 855.00K sh · $12.26M · Q2 2026
- Retirement Planning Co of New England, Inc. 612.33K sh · $6.72M · Q3 2026
- Mystic Asset Management, Inc. 355.38K sh · $3.90M · Q3 2026
- Stonepine Capital Management, LLC 258.70K sh · $3.71M · Q2 2026
- Propel Bio Management, LLC 253.54K sh · $3.64M · Q2 2026
- Diametric Capital, LP 231.47K sh · $3.32M · Q2 2026
More on KINGDON CAPITAL MANAGEMENT, L.L.C.
FAQ
How long has KINGDON CAPITAL MANAGEMENT, L.L.C. held ZVRA?
KINGDON CAPITAL MANAGEMENT, L.L.C. has disclosed ZVRA holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is KINGDON CAPITAL MANAGEMENT, L.L.C.'s current position in ZVRA?
As of Q2 2026, KINGDON CAPITAL MANAGEMENT, L.L.C. holds 775.00K shares of ZVRA (ZEVRA THERAPEUTICS INC), valued at $11.11M, representing 1.22% of its reported portfolio and ranking #29.
Has KINGDON CAPITAL MANAGEMENT, L.L.C. been buying or selling ZVRA?
In the latest 13F filing (Q2 2026), KINGDON CAPITAL MANAGEMENT, L.L.C. held unchanged its position in ZVRA. The position peaked in Q2 2026 at 775.00K shares.
Which other funds hold ZVRA?
Other major institutional holders of ZVRA include Nantahala Capital Management, LLC, 683 Capital Management, LLC, Retirement Planning Co of New England, Inc., among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.